258 related articles for article (PubMed ID: 14761182)
21. Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.
Rao PN; Chen QH; Knaus EE
J Med Chem; 2006 Mar; 49(5):1668-83. PubMed ID: 16509583
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and selective cyclooxygenase-2 inhibitory activity of a series of novel, nitric oxide donor-containing pyrazoles.
Ranatunge RR; Augustyniak M; Bandarage UK; Earl RA; Ellis JL; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schroeder JD; Shumway MJ; Tam SW; Trocha AM; Young DV
J Med Chem; 2004 Apr; 47(9):2180-93. PubMed ID: 15084117
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and effects on the COX-1 and COX-2 activity in human whole blood ex vivo of derivatives containing the [1]benzothienol-[3, 2-d]pyrimidin-4-one heterocyclic system.
Santagati A; Granata G; Marrazzo A; Santagati M
Arch Pharm (Weinheim); 2003 Sep; 336(9):429-35. PubMed ID: 14528491
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of 2,3-diarylpyrazines and quinoxalines as selective COX-2 inhibitors.
Singh SK; Saibaba V; Ravikumar V; Rudrawar SV; Daga P; Rao CS; Akhila V; Hegde P; Rao YK
Bioorg Med Chem; 2004 Apr; 12(8):1881-93. PubMed ID: 15051057
[TBL] [Abstract][Full Text] [Related]
25. 3-(2-Methoxytetrahydrofuran-2-yl)pyrazoles: a novel class of potent, selective cyclooxygenase-2 (COX-2) inhibitors.
Ranatunge RR; Earl RA; Garvey DS; Janero DR; Letts LG; Martino AM; Murty MG; Richardson SK; Schwalb DJ; Young DV; Zemtseva IS
Bioorg Med Chem Lett; 2004 Dec; 14(24):6049-52. PubMed ID: 15546727
[TBL] [Abstract][Full Text] [Related]
26. New cyclooxygenase-2/5-lipoxygenase inhibitors. 3. 7-tert-butyl-2, 3-dihydro-3,3-dimethylbenzofuran derivatives as gastrointestinal safe antiinflammatory and analgesic agents: variations at the 5 position.
Janusz JM; Young PA; Ridgeway JM; Scherz MW; Enzweiler K; Wu LI; Gan L; Chen J; Kellstein DE; Green SA; Tulich JL; Rosario-Jansen T; Magrisso IJ; Wehmeyer KR; Kuhlenbeck DL; Eichhold TH; Dobson RL
J Med Chem; 1998 Aug; 41(18):3515-29. PubMed ID: 9719605
[TBL] [Abstract][Full Text] [Related]
27. 3-[4-(methylsulfonyl)phenyl]-5-(trifluoromethyl)(2-pyridyl) phenyl ketone as a potent and orally active cyclooxygenase-2 selective inhibitor: synthesis and biological evaluation.
Khanapure SP; Augustyniak ME; Earl RA; Garvey DS; Letts LG; Martino AM; Murty MG; Schwalb DJ; Shumway MJ; Trocha AM; Young DV; Zemtseva IS; Janero DR
J Med Chem; 2005 Jun; 48(11):3930-4. PubMed ID: 15916445
[TBL] [Abstract][Full Text] [Related]
28. Novel terphenyls as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents.
Li JJ; Norton MB; Reinhard EJ; Anderson GD; Gregory SA; Isakson PC; Koboldt CM; Masferrer JL; Perkins WE; Seibert K; Zhang Y; Zweifel BS; Reitz DB
J Med Chem; 1996 Apr; 39(9):1846-56. PubMed ID: 8627608
[TBL] [Abstract][Full Text] [Related]
29. 1,3-Diaryl-4,5,6,7-tetrahydro-2H-isoindole derivatives: a new series of potent and selective COX-2 inhibitors in which a sulfonyl group is not a structural requisite.
Portevin B; Tordjman C; Pastoureau P; Bonnet J; De Nanteuil G
J Med Chem; 2000 Nov; 43(24):4582-93. PubMed ID: 11101350
[TBL] [Abstract][Full Text] [Related]
30. Design and synthesis of acyclic triaryl (Z)-olefins: a novel class of cyclooxygenase-2 (COX-2) inhibitors.
Uddin MJ; Rao PN; Knaus EE
Bioorg Med Chem; 2004 Nov; 12(22):5929-40. PubMed ID: 15498669
[TBL] [Abstract][Full Text] [Related]
31. Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect.
Chen XH; Bai JY; Shen F; Bai AP; Guo ZR; Cheng GF
Acta Pharmacol Sin; 2004 Jul; 25(7):927-31. PubMed ID: 15210067
[TBL] [Abstract][Full Text] [Related]
32. Diarylspiro[2.4]heptenes as orally active, highly selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationships.
Huang HC; Li JJ; Garland DJ; Chamberlain TS; Reinhard EJ; Manning RE; Seibert K; Koboldt CM; Gregory SA; Anderson GD; Veenhuizen AW; Zhang Y; Perkins WE; Burton EG; Cogburn JN; Isakson PC; Reitz DB
J Med Chem; 1996 Jan; 39(1):253-66. PubMed ID: 8568815
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and biological evaluation of N-acetyl-2-(or 3-)carboxymethylbenzenesulfonamides as cyclooxygenase isozyme inhibitors.
Chen QH; Rao PN; Knaus EE
Bioorg Med Chem; 2005 Aug; 13(15):4694-703. PubMed ID: 15914011
[TBL] [Abstract][Full Text] [Related]
34. New water-soluble sulfonylphosphoramidic acid derivatives of the COX-2 selective inhibitor cimicoxib. A novel approach to sulfonamide prodrugs.
Almansa C; Bartrolí J; Belloc J; Cavalcanti FL; Ferrando R; Gómez LA; Ramis I; Carceller E; Merlos M; García-Rafanell J
J Med Chem; 2004 Oct; 47(22):5579-82. PubMed ID: 15481993
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and cyclooxygenase-2 inhibiting property of 1,5-diarylpyrazoles with substituted benzenesulfonamide moiety as pharmacophore: Preparation of sodium salt for injectable formulation.
Pal M; Madan M; Padakanti S; Pattabiraman VR; Kalleda S; Vanguri A; Mullangi R; Mamidi NV; Casturi SR; Malde A; Gopalakrishnan B; Yeleswarapu KR
J Med Chem; 2003 Sep; 46(19):3975-84. PubMed ID: 12954051
[TBL] [Abstract][Full Text] [Related]
36. Sulfonamido, azidosulfonyl and N-acetylsulfonamido analogues of rofecoxib: 4-[4-(N-acetylsulfonamido)phenyl]-3-(4-methanesulfonylphenyl)-2(5H)furanone is a potent and selective cyclooxygenase-2 inhibitor.
Zarghi A; Praveen Rao PN; Knaus EE
Bioorg Med Chem Lett; 2004 Apr; 14(8):1957-60. PubMed ID: 15050636
[TBL] [Abstract][Full Text] [Related]
37. Novel synthesis of 3,4-diarylisoxazole analogues of valdecoxib: reversal cyclooxygenase-2 selectivity by sulfonamide group removal.
Di Nunno L; Vitale P; Scilimati A; Tacconelli S; Patrignani P
J Med Chem; 2004 Sep; 47(20):4881-90. PubMed ID: 15369392
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological characterization of a selective COX-2 inhibitor MF-tricyclic, [3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone], in multiple preclinical species.
Rowland SE; Clark P; Gordon R; Mullen AK; Guay J; Dufresne L; Brideau C; Cote B; Ducharme Y; Mancini J; Chan CC; Audoly L; Xu D
Eur J Pharmacol; 2007 Apr; 560(2-3):216-24. PubMed ID: 17316604
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of a new class of acyl derivatives of 3-amino-1-phenyl-4,5-dihydro-1H-pyrazol-5-one as potential dual cyclooxygenase (COX-1 and COX-2) and human lipoxygenase (5-LOX) inhibitors.
Cusan C; Spalluto G; Prato M; Adams M; Bodensieck A; Bauer R; Tubaro A; Bernardi P; Da Ros T
Farmaco; 2005 Apr; 60(4):327-32. PubMed ID: 15848208
[TBL] [Abstract][Full Text] [Related]
40. Effect of COX-1 and COX-2 inhibition on induction and maintenance of carrageenan-evoked thermal hyperalgesia in rats.
Dirig DM; Isakson PC; Yaksh TL
J Pharmacol Exp Ther; 1998 Jun; 285(3):1031-8. PubMed ID: 9618405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
